(Q51896759)

English

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.

scientific article published on 27 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status. (English)

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

4

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

object named as

David B Hogan

6

0 references

Kenneth Rockwood

1

object named as

Kenneth Rockwood

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

author name string

John Fisk

3

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Holly Tuokko

5

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Christina Wolfson

7

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Ian McDowell

8

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

publication date

27 November 2007

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Neuroepidemiology

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

29

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

3-4

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

201-207

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Statins and cognitive function in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Relation of plasma lipids to Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Cholesterol, statins and dementia.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Spectrum of disease in vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Subtype of mild cognitive impairment and progression to dementia and death

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Five-Year Follow-up of Cognitive Impairment With No Dementia

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Outcomes of incident mild cognitive impairment in relation to case definition

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Is mild cognitive impairment a valid target of therapy

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Combination pharmacotherapy for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Statin Use and the Risk of Incident Dementia

1 reference

https://api.crossref.org/works/10.1159%2F000111583

21 January 2018

Identifiers

10.1159/000111583

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/18043005

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51896759&oldid=1598905872"